Monkeypox
📧 Sign up to get email alerts when something new happens for Monkeypox.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-08-07EMA Authorised: Imvanex (modified vaccinia Ankara - Bavarian Nordic (MVA-BN) virus) — Bavarian Nordic A/S
EMA has authorised Imvanex (MVA-BN) vaccine from Bavarian Nordic A/S for smallpox and monkeypox indications.
-
EMA approval · 2026-06-15EMA Authorised: Tecovirimat SIGA (tecovirimat) — SIGA Technologies Netherlands B.V.
The EMA authorized tecovirimat (SIGA) for multiple poxvirus infections, including monkeypox and smallpox, under the marketing authorization …
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: JYNNEOS Smallpox Vaccine in Adult Healthcare Personnel at Risk for Mpox in the Democratic Republic of the Congo [Phase 3]
Phase 3 trial of the JYNNEOS smallpox vaccine in adult healthcare personnel at risk for mpox in the Democratic Republic of the Congo has com…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Understanding MPXV Viral Clearance, Transmission Dynamics, and Mpox Vaccine Effectiveness in West Africa : Guinea
A ClinicalTrials.gov entry for a Guinea (West Africa) study assessing MPXV viral clearance, transmission dynamics, and mpox vaccine effectiv…
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: Comparability Trial of the MVA-BN Vaccine Manufactured in Different Production Cells [Phase 2]
Phase 2 comparability study evaluating the MVA-BN vaccine produced in different cell lines for monkeypox; the trial status is currently acti…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: A Phase 2 Randomized Multisite Trial to Inform Public Health Strategies Involving the Use of MVA-BN Vaccine for Mpox [Phase 2]
This Phase 2 randomized multisite trial evaluating the MVA-BN mpox vaccine for monkeypox has completed, and results have been posted to info…
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: A Clinical Study Investigating the Safety and Immune Responses After Immunization With Investigational Monkeypox Vaccines [Phase 1, Phase 2]
A combined Phase 1/2 trial of an investigational monkeypox vaccine by BioNTech completed, evaluating safety and immune responses.
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: A Clinical Trial Evaluating the Monkeypox Recombinant Protein Vaccine [Phase 1]
Phase 1 clinical trial evaluating a monkeypox recombinant protein vaccine in healthy volunteers; trial not yet recruiting, sponsored by Shan…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Prospective Study for the FOLLOW-UP of Human Monkeypox Cases and Smallpox Vaccinees at Risk
A prospective study to follow up human monkeypox cases and smallpox vaccinees at risk is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-12Clinical Trial Update: Ocular Complications of Mpox in the Democratic Republic Congo
A completed status update for NCT06579885 investigating ocular complications of mpox (monkeypox) in the Democratic Republic of Congo, sponso…
-
CLINICAL_TRIALS trial_result · 2026-03-04Clinical Trial Update: A Randomized Clinical Trial Investigating the Safety, Reactogenicity, and Immunogenicity After Immunization With an mRNA-based Mpox Vaccine Candidate in Africa [Phase 2]
Ongoing Phase 2 randomized trial evaluating the safety, reactogenicity, and immunogenicity of an mRNA-based Mpox vaccine candidate in Africa…
-
CLINICAL_TRIALS trial_result · 2026-03-04Clinical Trial Update: Tecovirimat in Non-hospitalized Patients With Monkeypox [Phase 3]
Tecovirimat is being studied in non-hospitalized monkeypox patients in a Phase 3 trial that has been suspended.
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: Assessment of Safety Profile of MVA-BN Vaccine in the PALM-007 Study in DRC [Phase 4]
A Phase 4 PALM-007 study in the Democratic Republic of Congo assessed the safety of the MVA-BN vaccine for monkeypox; results have been post…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Phase 3 Maternal Safety & Immunogenicity Trial of MVA-BN® in DRC [Phase 3]
ClinicalTrials.gov entry updates a Phase 3 safety and immunogenicity trial of the MVA-BN mpox vaccine in the Democratic Republic of Congo, n…
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BSY001 After Single/Multiple Doses. [Phase 1]
Early-phase Phase 1 trial to evaluate the safety, tolerability, and pharmacokinetics of BSY001 after single and multiple doses; currently re…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Prospective Follow-up After MVA-BN Booster Vaccination
The document describes a prospective follow-up study after MVA-BN booster vaccination for Monkeypox and confirms the trial is not yet recrui…
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: Neutralizing Power of Serum Antibodies - 2 [NA]
Clinical trial update indicating ongoing recruitment to evaluate neutralizing power of serum antibodies in COVID-19 patients with SARS-CoV-2…
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Investigating MPXV Viral Clearance in Mpox Cases and Secondary Attack Rate in Contacts
This ClinicalTrials.gov update shows an ongoing study evaluating mpox (monkeypox) viral clearance in mpox cases and the secondary attack rat…
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: Evaluate the Safety and Immunogenicity of the MVA-SIBP Vaccine in the Democratic Republic of the Congo [Phase 2]
A Phase 2 clinical trial update to evaluate the safety and immunogenicity of the MVA-SIBP vaccine for Monkeypox in the Democratic Republic o…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: Open-label, Multicenter Immunogenicity and Safety Study of MVA-BN Vaccine in Children From 2 Years to Less Than 12 Years of Age Compared to Adults for the Prevention of Smallpox, Mpox, and Related Orthopoxvirus Infections [Phase 2]
An open-label Phase 2 multicenter immunogenicity and safety study evaluating the MVA-BN vaccine in children aged 2 to under 12 years, compar…
-
EMA approval · 2025-11-10EMA Authorised: Tecovirimat SIGA (tecovirimat) — SIGA Technologies Netherlands B.V.
The EMA authorised tecovirimat (brand SIGA) for treatment of orthopoxvirus infections including cowpox, monkeypox, vaccinia infection, and s…
-
CLINICAL_TRIALS research · 2025-10-30Clinical Trial Update: New York City Observational Study of Mpox Immunity
An observational study in New York City led by NYU Langone Health to study mpox (monkeypox) immunity, currently enrolling by invitation.
-
EMA approval · 2025-10-20EMA Authorised: Imvanex (modified vaccinia Ankara - Bavarian Nordic (MVA-BN) virus) — Bavarian Nordic A/S
EMA authorised Imvanex (MVA-BN) from Bavarian Nordic A/S for protection against smallpox and monkeypox, expanding its indications to include…
-
CLINICAL_TRIALS research · 2025-10-16Clinical Trial Update: Evaluating the Human Immune Response to the JYNNEOS Vaccine [EARLY_Phase 1]
Early-phase trial evaluating the human immune response to the JYNNEOS vaccine. The study status is Active Not Recruiting.
-
CLINICAL_TRIALS trial_result · 2025-10-09Clinical Trial Update: Tecovirimat for Treatment of Monkeypox Virus [Phase 2]
A Phase 2 clinical trial evaluating tecovirimat for the treatment of monkeypox has completed, with results posted.